3ICO
| |
5C9C
| CRYSTAL STRUCTURE OF BRAF(V600E) IN COMPLEX WITH LY3009120 COMPND | Descriptor: | 1-(3,3-dimethylbutyl)-3-{2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl}urea, CHLORIDE ION, Serine/threonine-protein kinase B-raf | Authors: | Edwards, T, Abendroth, J, Chun, L. | Deposit date: | 2015-06-26 | Release date: | 2015-07-15 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers. Cancer Cell, 28, 2015
|
|
3GVC
| |
3H7F
| |
3HE2
| |
6N0W
| |
6NFE
| |
8CU9
| |
8CTR
| |
4WJM
| |
8GZC
| Crystal structure of EP300 HAT domain in complex with compound 10 | Descriptor: | (2~{R},4~{R})-4-fluoranyl-1-[1-(4-methoxyphenyl)cyclohexyl]carbonyl-~{N}-(1~{H}-pyrazolo[4,3-b]pyridin-5-yl)pyrrolidine-2-carboxamide, Histone acetyltransferase p300, ZINC ION | Authors: | Takahashi, M, Hanzawa, H. | Deposit date: | 2022-09-26 | Release date: | 2023-01-11 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor. J.Med.Chem., 66, 2023
|
|
4WNY
| |
4WSO
| |
4DQ8
| |
6NDS
| |
6NB2
| |
6NE6
| |
5IS2
| |
4DIE
| |
8DV0
| |
8SJ9
| Crystal structure of the H1 hemagglutinin COBRA X6 | Descriptor: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Dzimianski, J.V, DuBois, R.M. | Deposit date: | 2023-04-17 | Release date: | 2024-05-01 | Last modified: | 2024-06-05 | Method: | X-RAY DIFFRACTION (3.25 Å) | Cite: | Structural basis for the broad antigenicity of the computationally optimized influenza hemagglutinin X6. Structure, 2024
|
|
8GHK
| |
8DTC
| |
8DT6
| |
8DTE
| |